What should be done if hybridoma antibody yield fluctuates greatly after changing the fetal bovine serum lot?

If a substantial amount of the new batch has already been purchased, you can try gradient acclimation. Transition gradually from old to new serum at ratios of 3:7, 5:5, and 7:3, passaging 2-3 generations at each ratio while monitoring viability and antibody titer. Some hybridoma clones can adapt to the new batch after 5-10 passages, and productivity will recover, but not all clones can recover, and the time cost must also be factored in. If the project timeline is tight, I recommend reserving the old batch for main production and using the new batch only for preliminary or non-critical experiments. You can also supplement with 1-2 mM sodium pyruvate or non-essential amino acids, which sometimes improves the state during the adaptation period.

Besides serum, it is recommended to investigate several easily overlooked points: a new lot may differ from the old lot in osmolality, pH, and glutamine concentration; if serum is not thoroughly mixed after freeze-thaw, stratification of proteins and lipids can also cause fluctuations in culture performance. You can check the CoA and compare endotoxin, hemoglobin, and total protein with the old lot. In addition, hybridoma inoculation density, feeding timing, and shake flask/plate lot may also be contributing factors. When we change serum, we generally keep the basal medium and supplements fixed and change only serum as the single variable; otherwise, it is difficult to attribute the cause.

Once serum screening is complete, stockpiling a large quantity is standard practice. I usually first ask the distributor for small samples from 2-3 candidate lots, and after selecting one, I stock up enough for the entire project cycle in one go. Calculating 6-8 bottles per month, I prepare at least 12-18 months' worth. Aliquot into 50 mL/tube, cryopreserve at -80°C, and keep only short-term at -20°C. Freezing the same lot for two years has a controllable impact on most hybridomas, but the prerequisite is that aliquoting is aseptic and repeated freeze-thaw cycles are avoided. Every six months, pull one tube to test for sterility, endotoxin, and antibody expression. Don't wait until you're almost out before sourcing more; it's easy to end up in a passive position.

From a management perspective, it is recommended to establish dual-brand or dual-lot backup. Do not rely solely on one South American brand; simultaneously evaluate Australian-source or domestic fetal bovine serum for parallel testing in hybridoma culture. After selecting a qualified lot, sign a lot-lock agreement with the distributor and have the supplier reserve it in cold storage to prevent it from being taken by other laboratories. Before large-scale stocking, perform accelerated stability testing or at least three passage tests. Our laboratory also retains a "gold standard" serum lot for quality control comparison. Before a new lot is released, it must achieve at least 80% of the antibody yield of the old lot.

Batch-to-batch variation causing a 30% drop in yield is quite possible. Although the hybridoma morphology hasn't changed much, it is sensitive to hormones, growth factors, and lipids in the serum, and different batches from the same brand can vary. I suggest you first take 2-3 bottles from each of the old and new batches for small-scale parallel testing, comparing doubling time, viability, and antibody titer in the culture supernatant, and continue passaging for 3-5 generations before evaluating, not just the first 48 hours. If it is confirmed that the new batch causes a 30% drop in yield, I will return it or switch batches rather than force its use. We encountered something similar before, and switching back to the old lot number restored performance.